English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/234274
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorFlorensa-Zanuy, Eva-
dc.contributor.authorArchitravo, Annamaria-
dc.contributor.authorAdell, Albert-
dc.contributor.authorGarro-Martínez, Emilio-
dc.contributor.authorCastro, Elena-
dc.contributor.authorDíaz, Álvaro-
dc.contributor.authorPazos, Ángel-
dc.contributor.authorPilar-Cuéllar, Fuencisla-
dc.date.accessioned2021-03-11T12:22:02Z-
dc.date.available2021-03-11T12:22:02Z-
dc.date.issued2020-09-14-
dc.identifier.citation33rd ECNP Congress Virtual (2020)-
dc.identifier.urihttp://hdl.handle.net/10261/234274-
dc.descriptionResumen del trabajo presentado en el 33rd ECNP Congress Virtual, celebrado en modalidad virtual del 12 al 15 de septiembre de 2020.-
dc.description.abstractMajor Depression is an incapacitating disease spread worldwide. As its etiology is still unknown, some hypotheses have been postulated, being the neuro-inflammatory one of the most recent. The current treatment for depression is far from optimal and there is an urgent need to find fast-acting drugs with fewer side effects. In this regard, cannabidiol (CBD), the major non-psychotropic component of , appears as a promising antidepressant drug. We have evaluated CBD’s behavioural and molecular effects in a neuro-inflammatory model of depression induced by lipopolysaccharide (LPS).-
dc.description.sponsorshipThis research was supported by the Ministerio de Economía y Competitividad (SAF2015-67457-R MINECO/FEDER), the Ministerio de Ciencia Innovación y Universidades (RTI2018-097534-B-I00), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM CB/07/09/0029).-
dc.languageeng-
dc.relationMINECO/ICTI2013-2016/SAF2015-67457-R-
dc.relationMICIU/ICTI2017-2020/RTI2018-097534-B-I00-
dc.relationRTI2018-097534-B-I00/AEI/10.13039/501100011033-
dc.rightsopenAccess-
dc.subjectMood disorders-
dc.subjectNeuro-inflammatory/ auto-immune-
dc.subjectPharmacology-
dc.titleAntidepressant-like effect and molecular mechanism of action of cannabidiol in the lipopolysaccharide model of depression in mice-
dc.typepóster de congreso-
dc.date.updated2021-03-11T12:22:03Z-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)-
dc.contributor.funderAgencia Estatal de Investigación (España)-
dc.contributor.funderCentro de Investigación Biomédica en Red Salud Mental (España)-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100011033es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100006751es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
Appears in Collections:(IBBTEC) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
834196.pdf43,02 kBUnknownView/Open
Show simple item record
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.